Studies have shown that the interplay between Aβ and tau pathologies leads to neuronal loss and synaptic damage (Samura et al., 2006; Shin et al., 2007), resulting in memory decline in AD (Ribé et al., 2005). This evidence concerns the gene MAPT and Alzheimer disease.